SUMMA RX LABORATORIES INC
10QSB, EX-27, 2000-09-26
PHARMACEUTICAL PREPARATIONS
Previous: SUMMA RX LABORATORIES INC, 10QSB, 2000-09-26
Next: SUMMA RX LABORATORIES INC, 10KSB40, 2000-09-26



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANICAL INFORMATION EXTRACTED FROM FORM 10-QSB
FOR THE QUARTER ENDED JANUARY 31, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FORM 10-QSB FOR THE QUARTER ENDED JANUARY 31, 2000.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          APR-30-2000
<PERIOD-START>                             MAY-01-2000
<PERIOD-END>                               JAN-31-2000
<CASH>                                       1,746,926
<SECURITIES>                                         0
<RECEIVABLES>                                  308,307
<ALLOWANCES>                                   142,162
<INVENTORY>                                    354,642
<CURRENT-ASSETS>                             2,364,008
<PP&E>                                       2,066,535
<DEPRECIATION>                                 660,697
<TOTAL-ASSETS>                               3,771,041
<CURRENT-LIABILITIES>                        1,221,988
<BONDS>                                        380,000
                                0
                                          0
<COMMON>                                        31,458
<OTHER-SE>                                   2,137,595
<TOTAL-LIABILITY-AND-EQUITY>                 3,771,041
<SALES>                                      2,623,431
<TOTAL-REVENUES>                             4,510,150
<CGS>                                        2,082,157
<TOTAL-COSTS>                                2,850,841
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              39,884
<INCOME-PRETAX>                              1,619,465
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          1,619,465
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,619,465
<EPS-BASIC>                                        .51
<EPS-DILUTED>                                      .51


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission